A mural honoring scientists hung in Pfizer’s NYC lobby for 60 years. Now it’s up for grabs By Cedar Attanasio - Associated Press Shares
Biden has mild symptoms and no fever as he deals with COVID-19, doctor says By Tom Howell Jr. - The Washington Times Shares
Kansas sues Pfizer over purportedly false claims its COVID-19 shot was ‘safe and effective’ By Alex Swoyer - The Washington Times Shares
Biden’s latest equity push could backfire and reduce salaries By Jeff Mordock - The Washington Times Shares
Study of 99 million COVID-vaccinated people finds links to brain, heart problems By Staff - The Washington Times Shares
As legal challenges mount, some companies retool diversity and inclusion programs By Alexandra Olson and Haleluya Hadero and Anne D'Innocenzio - Associated Press Shares
DEI opponents are using a 1866 Civil Rights law to challenge equity policies in the workplace By Anne D'Innocenzio and Alexandra Olson - Associated Press Shares
Stock market today: Wall Street ticks slightly higher ahead of Fed call on interest rates By Elaine Kurtenbach and Matt Ott - Associated Press Shares
Texas sues Pfizer over COVID-19 vaccine: ‘The pandemic did not end; it got worse’ By Victor Morton - The Washington Times Shares
Once-free COVID-19 treatments to enter market with hefty price tag By Amanda Seitz - Associated Press Shares
FDA approves updated booster shot for COVID-19 ahead of fall campaign By Tom Howell Jr. - The Washington Times Shares
FDA approves RSV vaccine for use in pregnant women to pass immunity to newborns By Tom Howell Jr. - The Washington Times Shares
Tornado damage to Pfizer plant unlikely to cause major drug supply shortages, FDA says By Hannah Schoenbaum - Associated Press Shares
Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need By Tom Murphy - Associated Press Shares
Pfizer pharmaceutical plant in North Carolina badly damaged by tornado, company says By Ben Finley and Hannah Schoenbaum - Associated Press Shares
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season By Matthew Perrone - Associated Press Shares
Judge unmasks gang of Biden staffers who stifled speech on social media By Susan Ferrechio - The Washington Times Shares
FDA advisers consider changing COVID vaccine to target latest omicron strain By Lauran Neergaard and Mike Stobbe - Associated Press Shares
